BRAF mutations occur early in serrated colorectal cancers, but their long-term influence on tissue homeostasis is poorly characterized. We investigated the impact of short-term (3 days) and long-term (6 months) expression of BrafV600E in the intestinal tissue of an inducible mouse model. We show that BrafV600E perturbs the homeostasis of intestinal epithelial cells, with impaired differentiation of enterocytes emerging after prolonged expression of the oncogene. Moreover, BrafV600E leads to a persistent transcriptional reprogramming with enrichment of numerous gene signatures indicative of proliferation and tumorigenesis, and signatures suggestive of metabolic rewiring. We focused on the top-ranking cholesterol biosynthesis signature and confirmed its increased expression in human serrated lesions. Functionally, the cholesterol lowering drug atorvastatin prevents the establishment of intestinal crypt hyperplasia in BrafV600E-mutant mice. Overall, our work unveils the long-term impact of BrafV600E expression in intestinal tissue and suggests that colorectal cancers with mutations in BRAF might be prevented by statins.
BRAFV600E-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism / P. Rzasa, S. Whelan, P. Farahmand, H. Cai, I. Guterman, R. Palacios-Gallego, S.S. Undru, L. Sandford, C. Green, C. Andreadi, M. Mintseva, E. Parrott, H. Jin, F. Hey, S. Giblett, N.B. Sylvius, N.S. Allcock, A. Straatman-Iwanowska, R. Feuda, C. Tufarelli, K. Brown, C. Pritchard, A. Rufini. - In: COMMUNICATIONS BIOLOGY. - ISSN 2399-3642. - 6:1(2023 Sep 21), pp. 962.1-962.16. [10.1038/s42003-023-05331-x]
BRAFV600E-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
A. Rufini
Ultimo
2023
Abstract
BRAF mutations occur early in serrated colorectal cancers, but their long-term influence on tissue homeostasis is poorly characterized. We investigated the impact of short-term (3 days) and long-term (6 months) expression of BrafV600E in the intestinal tissue of an inducible mouse model. We show that BrafV600E perturbs the homeostasis of intestinal epithelial cells, with impaired differentiation of enterocytes emerging after prolonged expression of the oncogene. Moreover, BrafV600E leads to a persistent transcriptional reprogramming with enrichment of numerous gene signatures indicative of proliferation and tumorigenesis, and signatures suggestive of metabolic rewiring. We focused on the top-ranking cholesterol biosynthesis signature and confirmed its increased expression in human serrated lesions. Functionally, the cholesterol lowering drug atorvastatin prevents the establishment of intestinal crypt hyperplasia in BrafV600E-mutant mice. Overall, our work unveils the long-term impact of BrafV600E expression in intestinal tissue and suggests that colorectal cancers with mutations in BRAF might be prevented by statins.File | Dimensione | Formato | |
---|---|---|---|
First submission pre_print.pdf
accesso aperto
Tipologia:
Pre-print (manoscritto inviato all'editore)
Dimensione
6 MB
Formato
Adobe PDF
|
6 MB | Adobe PDF | Visualizza/Apri |
s42003-023-05331-x.pdf
accesso aperto
Descrizione: Article
Tipologia:
Publisher's version/PDF
Dimensione
4.62 MB
Formato
Adobe PDF
|
4.62 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.